Walter's Pharmacy Recalls Tobramycin Ophthalmic Solution Due to Sterility Concerns
Walter's Pharmacy is recalling Tobramycin 14 mg/mL Ophthalmic Solution because the product lacks assurance of sterility. The recall affects 10 mL bottles distributed in Pennsylvania.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a risk-of-harm product (sterility failure in an ophthalmic solution) where injury has not yet been reported, which aligns with the 'High' severity criteria in the rubric.
Plain-English summary
Walter's Pharmacy is recalling specific bottles of Tobramycin 14 mg/mL Ophthalmic Solution. The recall was initiated because the product lacks assurance of sterility. The affected product is a 10 mL bottle, prescription only, with NDC 99999-9996-60 and Lot # 020216.
The recall is limited to the state of Pennsylvania. Walter's Pharmacy is the recalling firm. The source text does not specify the number of units recalled or report any illnesses or injuries associated with the product.
Consumers who have this product should stop using it and contact their healthcare provider or Walter's Pharmacy for further instructions.
The recalled product
- Product
- Tobramycin 14 mg/mL Ophth Solution, 10mL bottle, Rx only, Walter's Pharmacy, 401 N 17th St, Allentown, PA 610-435-4706, NDC 99999-9996-60
- Manufacturer
- Walter's Pharmacy
- Category
- Drug — Ophthalmic Solution
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: 020216
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 13 recalled by Walter's Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · Walter's Pharmacy
See all →- SevereWalter's Pharmacy Recalls Silver Nitrate Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
- SevereWalter's Pharmacy Recalls Tobramycin Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
- SevereWalter's Pharmacy Recalls Acetylcysteine Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
- SevereWalter's Pharmacy Recalls Cefazolin Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
- SevereWalter's Pharmacy Recalls Edetate Disodium Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereLiberty Drug Recalls Tobramycin Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- SevereNora Apothecary Recalls Tobramycin Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
- SevereMartin Avenue Pharmacy Recalls Tobramycin Eye Drops for Sterility Concerns
FDA (Drugs) · 2014-11-05
- SevereVancomycin Ophthalmic Solution Recalled Due to Sterility Concerns
FDA (Drugs) · 2022-03-23
- SevereMedical Center Pharmacy Recalls Vancomycin Opthal Drops Due to Sterility Concerns
FDA (Drugs) · 2020-04-08
- SevereHealth Innovations Pharmacy Recalls Fortifed Tobramycin Ophthalmic Solution
FDA (Drugs) · 2015-05-20